BruxZir® Full-Strength Zirconia offers dentists a solution for their most functionally demanding cases. The original leader in high strength, BruxZir Full-Strength has been prescribed for millions of patients around the…
Virtual Assistants are dedicated, real team members embedded into a dental practice’s daily operations as an extension of the in-office staff. They work on the practice’s schedule, with after-hours coverage…
Isolite is your all-in-one solution for efficient dentistry. Between tight schedules, rising patient expectations, and increasing operational demands, efficiency has never mattered more. That’s where Isolite comes in. Isolite is…
Garfield officially established an exclusive DSO refining program in 2017 to serve emerging, mid-market, and enterprise-level dental organizations. Our mission is to provide an organized, turnkey refining service that has…
Zuub provides the insurance verification infrastructure for DSOs—delivering accurate, automation-ready eligibility and benefits data via API, software platform, or hybrid models. Zuub connects directly to all major payers, providing normalized,…
The fastest payer payments in healthcare. PayerSync™ reduces manual work and simplifies insurance payment processing, Explanation of Payments (EOPs), and posting. Practices can now optimize cash flow, minimize errors, and…
NeoDrys saliva absorbents are used to keep a dry field during a procedure. They are placed against the cheek, along the parotid gland, and can absorb saliva for up to…
NeoBurr is our line of tungsten carbide burs, made with blended neck technology to provide superior strength and durability. We also use single piece construction for most of catalog, removing…
NeoDiamond is the leading SPU Diamond in the US, launched in 1989. We offer a variety of shapes of shapes, including our Minimally Invasive Diamonds, Xtra Coarse Diamonds, and our…
Kulzer’s Precious Metal Refining Service has been honored with the prestigious Dental Advisor Top Refiner Award for three consecutive years: 2023, 2024, and 2025. Achieving an impressive 98% clinical rating…